FDA approves Madrigal’s NASH drug, marking the first-ever treatment for the liver diseaseNicole DeFeudisEditorMadrigal Pharmaceuticals’ NASH drug won an accelerated approval on Thursday, becoming the first treatment for a liver disease that for years has vexed scientists and investors. The medication, resmetirom, was approved under the brand name Rezdiffra for patients with stage 2 and...